Medipharm Labs Corp (LABS.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 41,961 | 33,062 | 22,117 | 21,711 | 36,012 |
| Cost of Goods | 29,156 | 27,207 | 24,031 | 36,957 | 79,990 |
| Gross Profit | 12,805 | 5,855 | -1,914 | -15,246 | -43,978 |
| Operating Expenses | 23,373 | 23,602 | 26,877 | 27,763 | 27,050 |
| Operating Income | -10,568 | -17,747 | -28,791 | -43,009 | -71,028 |
| Interest Expense | 576 | 365 | 31 | 10,506 | 7,875 |
| Other Income | 450 | 4,753 | -1,167 | -1,173 | 6,803 |
| Pre-tax Income | -10,694 | -13,359 | -29,989 | -54,688 | -72,100 |
| Income Tax | 0 | -276 | -6 | 113 | -4,990 |
| Net Income Continuous | -10,694 | -13,083 | -29,983 | -54,801 | -67,110 |
| Minority Interests | N/A | N/A | N/A | 0 | 757 |
| Net Income | $-10,694 | $-13,083 | $-29,983 | $-54,801 | $-66,353 |
| EPS Basic Total Ops | -0.03 | -0.04 | -0.11 | -0.22 | -0.48 |
| EPS Basic Continuous Ops | -0.03 | -0.04 | -0.11 | -0.22 | -0.48 |
| EPS Diluted Total Ops | -0.03 | -0.04 | -0.11 | -0.22 | -0.48 |
| EPS Diluted Continuous Ops | -0.03 | -0.04 | -0.11 | -0.22 | -0.48 |
| EBITDA(a) | $-7,518 | $-10,478 | $-27,086 | $-38,549 | $-53,418 |